Alembic Pharma gets USFDA nod for Desonide Ointment

Alembic Pharma gets USFDA nod for Desonide Ointment Desonide Ointment, 0.05 per cent, is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, Alembic Pharmaceuticals sad in a BSE filing.

No comments:

Post a Comment